But can long COVID be fatal? The answer is complex and depends on multiple ... in extreme cases, a condition called pulmonary fibrosis, where scar tissue forms in the lungs and causes breathing ...

Idiopathic pulmonary fibrosis (IPF) is characterized by a progressive decline in lung function, worsening quality of life, and high mortality. However, the rate and pattern of progression of IPF ...

Pulmonary fibrosis is a relentless, potentially fatal disease where lung tissue scars and hardens over time. Often tied to smoking, the illness impairs lung function so that patients become short of ...

A treatment for fatal lung diseases such as idiopathic pulmonary fibrosis is being developed by Lung Therapeutics. The novel mechanism could have wider applications for other fibrotic diseases.

The term “progressive pulmonary fibrosis” or “PPF” is generally used to describe progressive lung fibrosis in an individual with an interstitial lung disease (ILD) other than idiopathic ...

Identifying the underlying causes of prolonged lung inflammation associated with radiographic abnormalities could be key understanding long COVID and other lung conditions, researchers say.

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

Idiopathic pulmonary fibrosis (IPF) is a severe, progressive, and generally fatal lung disease that causes inflammation ...

Mette-Marit's current course of treatment for pulmonary fibrosis may interfere with her planned duties over the coming weeks, the Norwegian Royal House said on Friday, October 11. 'Previous ...

Mizuho Securities analyst Graig Suvannavejh has maintained their bullish stance on INSM stock, giving a Buy rating on November 5. Graig ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX), a specialty pharmaceutical company, announced today that the United States (U.S.) Food and Drug Administration (FDA) granted Orphan Drug Designation and ...